Search
for

    Sort by

    Research 31–60 of 956

    1. An Investigation into the Effects of Water- and Fat-Soluble Vitamins in Alzheimer's and Parkinson's Diseases The Neuroscience Journal of Shefaye Khatam · 2023 · 10 citations
    2. Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease Journal of Neuroimmune Pharmacology · 2023 · 9 citations
    3. Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson’s Disease Cells · 2026
    4. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson’s disease Neuropharmacology · 2015 · 27 citations
    5. Aqueous Extract of Bacopa procumbens and the NAPEL Formulation Mitigate MPTP-Induced Neurotoxicity via Nrf2/HSF1/HIF-1α Signaling in a Parkinson’s Disease Model International Journal of Molecular Sciences · 2025
    6. Faculty Opinions recommendation of Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    7. Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases Faculty of Health; Institute of Health and Biomedical Innovation · 2012
    8. 25 years of ERβ: a personal journey Journal of molecular endocrinology · 2021 · 11 citations
    9. A machine learning and network framework to discover new indications for small molecules PLOS Computational Biology · 2020 · 8 citations
    10. The Charnoly body as a universal biomarker of cell injury Biomarkers and Genomic Medicine · 2014 · 6 citations
    11. Factors associated with early-onset androgenetic alopecia: A scoping review PLOS ONE · 2024
    12. The Rotterdam Study: 2012 objectives and design update European Journal of Epidemiology · 2011 · 247 citations
    13. 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction Neurobiology of Disease · 2018 · 26 citations
    14. Alopecia induced by dopamine agonists Neurology · 2002 · 21 citations
    15. Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by α‐synuclein triplication (Iowa kindred) Movement Disorders · 2011 · 31 citations
    16. Do Dermatoses Trigger Neurodegenerative Diseases? A Retrospective Observational Study 2025
    17. PAK4 signaling in health and disease: defining the PAK4–CREB axis Experimental & Molecular Medicine · 2019 · 81 citations
    18. Effets de médicaments gonadiques pour la neuroprotection du cerveau chez un modèle animal de la maladie de Parkinson Corpus Université Laval (Université Laval) · 2017
    19. Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases PLOS Genetics · 2012 · 87 citations
    20. Faculty Opinions recommendation of Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    21. Faculty Opinions recommendation of Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    22. A machine learning and network framework to discover new indications for small molecules bioRxiv (Cold Spring Harbor Laboratory) · 2019
    23. Transcranial photobiomodulation for brain diseases: review of animal and human studies including mechanisms and emerging trends Neurophotonics · 2024
    24. USO DE ESTIMULAÇÃO CEREBRAL PROFUNDA (DBS) PARA O TRATAMENTO DA DOENÇA DE PARKINSON Amplla Editora eBooks · 2022
    25. Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy Movement Disorders · 2011 · 4 citations
    26. Phytomedicine for neurodegenerative diseases: The road ahead Phytotherapy Research · 2024 · 18 citations
    27. Inorganic Nanomaterial for Biomedical Imaging of Brain Diseases Molecules · 2021 · 13 citations
    28. Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases Molecular Neurodegeneration · 2024 · 26 citations
    29. Biological Activities of 2,3,5,4′-Tetrahydroxystilbene-2-O-<i>β</i>-D-Glucoside in Antiaging and Antiaging-Related Disease Treatments Oxidative medicine and cellular longevity · 2016 · 43 citations
    30. Atypical formations of gintonin lysophosphatidic acids as new materials and their beneficial effects on degenerative diseases 2023